Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan

Autor: Rodriguez Lanzi, Cecilia, Wei, Ran, Luo, Dingyuan, Mackenzie, Gerardo G.
Zdroj: In Neoplasia February 2022 24(2):133-144
Databáze: ScienceDirect